Cite
HARVARD Citation
Page, D. et al. (2015). Pre-operative immunotherapy with tumor cryoablation (cryo) plus ipilimumab (ipi) induces potentially favorable systemic and intratumoral immune effects in early stage breast cancer (ESBC) patients. Journal for immunotherapy of cancer. 3 (1), pp. 1-2. [Online].